These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1968096)

  • 1. Acute HIV-1 infection: clinical and biological study of 12 patients.
    Sinicco A; Palestro G; Caramello P; Giacobbi D; Giuliani G; Paggi G; Sciandra M; Gioannini P
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):260-5. PubMed ID: 1968096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory characteristics of HIV-1 infection in Zimbabwe.
    Katzenstein DA; Latif AS; Grace SA; Basset M; Mashu A; de Villiers DM; Carrow EW; Hendry RM; Marowa E; Emmanuel JC
    J Acquir Immune Defic Syndr (1988); 1990; 3(7):701-7. PubMed ID: 1972189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
    MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
    Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.
    Hashida S; Hashinaka K; Ishikawa S; Ishikawa E
    J Clin Lab Anal; 1997; 11(5):267-86. PubMed ID: 9292394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of serum antigen and antibody concentration with clinical features in HIV infection.
    Ellaurie M; Rubinstein A
    Arch Dis Child; 1991 Feb; 66(2):200-3. PubMed ID: 1705767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV infection and T-lymphocyte behavior: results of a study in Palermo].
    Cangelosi C; Giardina RA; Pecoraro G; Marcianò R; Vitale MG; Gullotti A; Caronia F; Spanò C
    Ann Ig; 1989; 1(1-2):45-50. PubMed ID: 2483080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
    Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
    Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 neutralizing antibodies in urine from seropositive individuals.
    Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal conditions of immune complex transfer enzyme immunoassays for antibody IgGs to HIV-1 using recombinant p17, p24, and reverse transcriptase as antigens.
    Hashida S; Ishikawa S; Hashinaka K; Nishikata I; Oka S; Shimada K; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Clin Lab Anal; 1998; 12(2):98-107. PubMed ID: 9524294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection.
    Ohlsson-Wilhelm BM; Cory JM; Kessler HA; Eyster ME; Rapp F; Landay A
    J Infect Dis; 1990 Nov; 162(5):1018-24. PubMed ID: 1977803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent immune complexes and abnormal CD4/CD8 ratios in HIV infection.
    Roy S; Morrow WJ; Christian C; Khayam-Bashi H; Busch MP; McCarthy R; Rodgers RP; Vyas GN
    J Acquir Immune Defic Syndr (1988); 1990; 3(2):134-8. PubMed ID: 1967308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
    Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
    Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and western blot.
    Barbé F; Klein M; Badonnel Y
    Ann Biol Clin (Paris); 1994; 52(5):341-5. PubMed ID: 7856933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course.
    Chargelegue D; Colvin BT; O'Toole CM
    AIDS; 1993 Nov; 7 Suppl 2():S87-90. PubMed ID: 7909231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals.
    Schuurman HJ; Krone WJ; Broekhuizen R; Goudsmit J
    Am J Pathol; 1988 Dec; 133(3):516-24. PubMed ID: 3059804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
    Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
    Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
    J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value.
    Robert-Guroff M; Roilides E; Muldoon R; Venzon D; Husson R; Marshall D; Gallo RC; Pizzo PA
    J Infect Dis; 1993 Mar; 167(3):538-46. PubMed ID: 7680059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological correlates of immune-complex-dissociated HIV-1 p24 antigen in HIV-1-infected children.
    Duiculescu DC; Geffin RB; Scott GB; Scott WA
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):807-15. PubMed ID: 7912730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV.
    Lefrère JJ; Couroucé AM; Lucotte G; Boitard C; Kaplan C; Nicolas JC; Bricout F; Lambin P; Doinel C; Muller JY
    AIDS; 1988 Aug; 2(4):287-90. PubMed ID: 2902864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.